[{"id":"f86cb415-8cd4-40d8-95a3-dfb20ad7fabe","acronym":"","url":"https://clinicaltrials.gov/study/NCT05508620","created_at":"2022-08-19T17:10:15.504Z","updated_at":"2024-07-02T16:36:05.018Z","phase":"Phase 1","brief_title":"A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05508620","lead_sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","biomarkers":" TSC2 • TSC1","pipe":"","alterations":" ","tags":["TSC2 • TSC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 270","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2022-08-23"}]